Compare PLSE & PRLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLSE | PRLB |
|---|---|---|
| Founded | 2014 | 1999 |
| Country | United States | United States |
| Employees | N/A | 2280 |
| Industry | Medical/Dental Instruments | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.7B |
| IPO Year | 2015 | 2011 |
| Metric | PLSE | PRLB |
|---|---|---|
| Price | $25.47 | $70.11 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $22.00 | ★ $53.00 |
| AVG Volume (30 Days) | ★ 328.8K | 144.4K |
| Earning Date | 05-07-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 33.33 |
| EPS | N/A | ★ 0.33 |
| Revenue | N/A | N/A |
| Revenue This Year | $840.00 | $8.56 |
| Revenue Next Year | $287.54 | $6.89 |
| P/E Ratio | ★ N/A | $218.85 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.56 | $36.15 |
| 52 Week High | $27.98 | $73.11 |
| Indicator | PLSE | PRLB |
|---|---|---|
| Relative Strength Index (RSI) | 59.41 | 62.42 |
| Support Level | $17.58 | $47.69 |
| Resistance Level | $26.30 | N/A |
| Average True Range (ATR) | 1.75 | 3.27 |
| MACD | 0.56 | 0.22 |
| Stochastic Oscillator | 69.75 | 80.89 |
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.
Proto Labs Inc is an on-demand manufacturer of custom parts for prototyping and short-run production. The company offers developers and engineers quick-turn production services to reduce the time to market. The Lab uses injection molding, computer numerical control machining, and 3-D printing, and sheet metal to manufacture custom parts for its clients. The company services clients' needs for prototype solutions, parts for testing procedures, bridge production capabilities during disruptions in manufacturing processes, limited-quantity requests, and end-of-life production support. Geographically, a majority of the company's revenue is derived from the United States and the rest from Europe.